According to a recent Wall Street Journal Online/Harris Interactive Health-Care Poll, four out of five (80%) U.S. adults indicate that they favor allowing people to import prescription drugs from Canada and other countries if they are much less expensive. A vast majority (84%) of the public strongly or somewhat agrees that the law banning pharmaceutical imports is intended to protect drug companies’ profits, while only thirty-six percent say this law helps protect Americans from potentially harmful drugs.These are some of the results of an online survey of 2,295 U.S. adults conducted by Harris Interactive(R) between August 23 and 25, 2006 for The Wall Street Journal Online’s Health Industry Edition (http://www.wsj.com/health).While some pharmaceutical companies want to make it impossible for Canadian pharmacies to sell drugs over the Internet, a majority of adults (72%) state that this policy is very or somewhat unreasonable. Additionally, 83 percent agree that it should be legal to import drugs from Canada that are approved and vetted by Health Canada, Canada’s equivalent of the Food and Drug Administration (FDA). Since last year, Customs has been confiscating packages mailed to U.S. consumers by Canadian pharmacies, with 37,154 packages seized as of July 2006. A majority (77%) agrees that confiscating drugs at the Canadian border jeopardizes the health of some Americans, and very few (6%) feel that those who regularly order pharmaceuticals from Canada should be fined or arrested.Interestingly, only one out of ten (11%) adults say they have bought prescription drugs from a pharmacy in Canada or another foreign country (either by going there, on the Internet, or by mail) in order to save money, but that percentage has doubled since 2002. Adults living in the West (16%) are more likely to indicate that they have bought prescription drugs from a pharmacy in Canada or another foreign country, as compared those living in the South (11%), East (8%) or Midwest (8%).
Related Articles Read More >

Confidently navigate the transition from bench to batch

FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
